Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2
E. Tayeb-Fligelman, X. Cheng, C. Tai, J. T. Bowler, S. Griner, M. R. Sawaya, P. M. Seidler, Y. X. Jiang, J. Lu, G. M. Rosenberg, L. Salwinski, R. Abskharon, C.-T. Zee, K. Hou, Y. Li, , D. Eisenberg
The paper identifies amyloid-forming segments in SARS-CoV-2 Nucleoprotein and designs peptide inhibitors based on their atomic structures to target Covid-19.
bioRxiv · Mar 5, 2021 · PreprintBiochemistry